Circadian Adjusted LED Light's Effect in People Living in Elderly Housing
Launched by OVE ANDERSEN · Aug 23, 2017
Trial Information
Current as of June 16, 2025
Completed
Keywords
ClinConnect Summary
Due to the technical requirements, CALED will not be installed in all elderly housing facilities at Sundhedshuset, Albertslund, Denmark, limiting the number of participants receiving the intervention to 24. CALED will be installed in the residents rooms/flats and in the common areas. Residents accepting participation will comprise the following (numbers are the maximal possible): 15 elderly with frailty receiving CALED as an intervention, 9 people with dementia receiving CALED as an intervention, and 15 elderly with frailty not receiving CALED during the trial as a control group (Group 3).
...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Group 1 and 2: Frail elderly (+65 years) and elderly (+50 years) with dementia, who live in the flats/rooms in Sundhedshuset, Albertslund, Denmark that have been chosen for a test installation of CALED will be invited to participate.
- • Group 3: Frail elderly (+65 years) who live in the flats/rooms in Sundhedshuset, Albertslund, Denmark that have not been chosen for a test installation of CALED will be invited to participate.
- Exclusion Criteria for Group 1, 2, 3:
- • Terminal illness
About Ove Andersen
Ove Andersen is a dedicated clinical trial sponsor renowned for its commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic solutions, the organization collaborates with healthcare professionals, researchers, and regulatory bodies to conduct rigorous clinical trials across various therapeutic areas. Ove Andersen prioritizes ethical standards, participant safety, and scientific integrity, ensuring that all trials are designed to meet the highest quality benchmarks. Through its comprehensive approach, the organization aims to contribute valuable insights to the medical community and facilitate the development of groundbreaking treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hvidovre, , Denmark
Patients applied
Trial Officials
Ove Andersen, PhD, DMSc
Study Chair
Clinical Research Centre, Copenhagen University Hospital Hvidovre, Denmark
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials